Skip to main content
. 2024 Oct 2;15:1470148. doi: 10.3389/fphar.2024.1470148

TABLE 1.

Overview of two DNA methylation inhibitors.

Drug name Chemical name Structure Main treatment First marketed year
Azacitidine 4-amino-1-β-D-ribofuranosyl-1,3,5-triazine-2(1H)-one C8H12N4O5 Myelodysplastic syndromes (MDS), Acute Myeloid Leukemia (AML), and Chronic Myeloid Leukemia 2004
Decitabine 5-azacitidine-2′-deoxycytidine C8H12N4O4 Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) 2012